Eden Research Share Discussion Threads

[brucie5] 06/12/2019 12:02

JakNife
6 Dec '19 - 10:02 - 7209 of 7210
0 0 0
.
-----------------------------------------------------------
Very cryptic there.
Jak, can you please tell us your prognostic for the share price as/when EDEN gets EPA regulatory clearance from MEV/CED? I need to know whether to be selling at this historic low point or not, as I am expecting these permissions to be RNS's fairly shortly. What's your opinion?

.
.
.
.

[supersonico] 06/12/2019 10:04

.Eden
.Planning ahead? Join us on 11 February 2020 in London for The Growth and Innovation Forum - the UK’s only growth and technology focussed investment show!

[supersonico] 06/12/2019 08:25

735 of 735
Readers may recall says poster mentioning it for the first time...…..LOL

[supersonico] 05/12/2019 06:21

Rob Cannings of @edenresearch
will now give us the latest on biostimulants including: the regulatory environment, changing modes of action & evidence for efficacy in potatoes #AgConf19

Why is this Interesting / Relevant? Here are some Dots...

supersonico - 23 Jul 2019 - 05:11:51 - 6613 of 7208
Eden Research - EDEN
Parked Dots and Wild Guesses.

The Guess here is that Eden have on going most likely Cedroz, but possibly Sipcam , related trials with Potatoes potentially related to PepsiCo/ Xinova synergy/colaboration. We have not been told anything about potatoes but Eden collect TweetLikes a plenty of Potato growers and their trade bodies. Lofty Powerscourt will have Potato related relationships and I'm not just talking about Nick Dibdens indulgences.

No Smoke and Mirrors here but possibly Smokey Bacon.

......Terpenes/ Terpenoids/ Nematicide / Post Harvest.

PepsiCo / FC5 Potato / Xinova / Eden

The Role of Terpenes as Protectors of the Potato Crop

1.4 Terpenes
Terpenoids constitute the largest and most widespread group of plant secondary
metabolites, and they display immense structural diversity. Terpenoids are formed from
linear arrangements of isoprene units, and are then rearranged and cyclised in order to form
the terpenoid carbon skeleton. Terpenoids are classified according to the number of
isoprene units from which they are constructed, and these classes include monoterpenes
(C10), sesquiterpenes (C15), diterpenes (C20), triterpenes (C30) and tetraterpenes (C40) to name
just a few (Stevens 1992). Terpene synthases, a large class of enzymes, are responsible for
the diversity observed in terpene carbon skeleton structures. The diversity in terpene
structure is also due to the fact that some terpene synthases produce multiple products
(Degenhardt, Köllner et al. 2009). Investigation into terpene synthases has been an active
area of plant metabolic engineering research in recent years due to the fact that the vast
diversity of terpenes may be exploited for biotechnological purposes (Singh and Sharma
2015). These compounds have an array of interesting properties, which may be exploited
for medicinal and agrochemical purposes, as well as for flavouring and in cosmetics. As the
field of synthetic biology develops, terpenes may be interesting and useful compounds to
investigate and exploit, due to their high level of diversity and the wide array of industries to
which they may be applied.

Terpenes have been identified in this study as being associated with potato crop losses in a
variety of different manners. The compound identified as a ‘hatching factor’ for Potato Cyst
Nematodes, which stimulates nematodes to hatch in the presence of the host plant, is a
triterpenoid produced by potatoes. Understanding of the ecological role and biosynthesis
of this triterpenoid will shed light on the reason for the production of this ‘hatching factor’
by the potato, and may also be critical in identifying solutions to the problem of Potato Cyst
Nematode infection.

5 Conclusions
This study has investigated two problems facing potato growers: Potato Cyst Nematode as a
pathogen of the potato crop, and the problem of sprouting inhibition whilst the potato crop is
in storage. Whilst the study has been relatively broad in scope, several key points have been
highlighted, which may be key to improving potato crop productivity, both with regards to
mitigating against pathogenic factors, and preventing losses in storage.

The role of terpenes, both as products of the potato, and as compounds used to protect the
potato, have been discussed throughout the study, and the conclusions drawn support the
statements made by Singh and Sharma (2015) suggesting that the vast array of terpenes may be
exploited for their biotechnological purposes. Furthermore, a deeper understanding of the
ecological role of terpenes produced by potato and other plants may result in highly specific
applications and uses for such metabolites.

[supersonico] 05/12/2019 06:11

No Crystal Ball needed when Lube arrive..

[supersonico] 04/12/2019 22:08

Guess what happens next?

[jammydodger1] 04/12/2019 20:05

Tonight you people need to research ALGWBIG PLANS 100,000,000 million. Credit facility about to be approved and signed by a leading UK asset managerMcap of this company is only 5m nowWill be multiples And way past 20pDnt be left out in the cold

[sandcrab2] 04/12/2019 19:24

What's the cash position here now?

[supersonico] 04/12/2019 00:09

Well as they are likely instigating the NDA's then your probably right about that.

[investingisatrickygame] 03/12/2019 22:20

TT, Bayer et al

[supersonico] 03/12/2019 19:12

who are the others you referred to .. Investing?

[investingisatrickygame] 03/12/2019 18:02

Let's hope you're right and there is one almighty RNS. I'm just not seeing that though.

[supersonico] 03/12/2019 15:33

Investing, you say
'I very much doubt others will co-ordinate all that you suggest'.

Who are the 'others' you mention?

If I was not under strict self imposed NDAs myself I could quite easily quote references to further substantiate my assertions regarding a shared formulation issue.

I have been the most consistent and accurate of this position for easily two years now and despite comfort updates from Eden my theory on parallel delays remains intact.

[investingisatrickygame] 03/12/2019 14:14

super,

If Eden says things are not in their control and that is their excuse/reason, I very much doubt others will co-ordinate all that you suggest.

In any event, TT appears to be a non event now unless you do believe a Johnson and Johnson type company is loitering in the background. TT seems full of puff to me.

Bayer is endlessly delayed and arguably not in control of Animal Health so that takes us fully back to Crop Protection which is where Eden is at, self-declared. I only wonder why they don't update their presentations if this is so and not now declare themselves in the Consumer Health and Animal Health markets until they know for sure that they are.

From Eden's website "Eden’s partner for animal health applications in North America, Bayer Animal Health, continues to make steady progress with the four products that it is commercialising: a shampoo, a conditioner, a spray and an oticetic flush."

I'd like an update on this. Is this so? is Bayer Animal Health continuing to make steady progress in commercialising these products or is this statement now out of date given they are selling this division of their business?

Bayer however, may be in bed with Eden with Sustaine for Crop Protection and that is an entirely different matter and opportunity.

14/5/2019 AGM Presentation hxxps://www.edenresearch.com/_userfiles/pages/files/r2019/agmpresentation2019.pdf

Pages 15 & 16, Bayer is a 'Commercial Partner'. All the other companies buy product from Eden and sell in the market.

What is the commercial aspect of Eden's relationship with Bayer, which Eden has been stating for years in presentations because I cannot see it. Can anyone else?

Why can't Eden simply tell us what the commercial relationship is with Bayer and don't say NDA's. Either it is a commercial relationship and public knowledge or Bayer's name needs to be removed from that group.

[supersonico] 03/12/2019 06:54

Correct and that isn't much to ask is it?

It is if Bayer/UPL /Eastman / Sipcam…short order Collaborators..etc have issues with the original IP and wish to tweak it to improve the formulation to better suit /match/ enhance it's original and their new application targets.

Improving Bayer's Dicamba drift issue with a slow release granular version would be one example of this.

Oh and where are the Tweaked Emergency country approvals?

#ThebigEdenShortorderTweak

AWGATWT.

[investingisatrickygame] 02/12/2019 22:23

"but they have justified the void of info and results behind ndas for far too long now,it really is time to start showing us the owners why we still invest,"

Correct and that isn't much to ask is it.

[supersonico] 02/12/2019 14:58

Small Change

Baronsmead VCT 3 Plc
10,260,471
4.95%
+60,080
0.50%
09/30/19

Baronsmead VCT 2 Plc
8,393,877
4.05%
-26,419
0.48%
09/30/19

[bjlk] 02/12/2019 14:55

Yep good points but they have justified the void of info and results behind ndas for far too long now , it really is time to start showing us the owners why we still invest, similarly if the tech is so good why cant Eden say no to ndas to further interest instead of jam, asteroid jam, unicorns in short order

[supersonico] 02/12/2019 13:25

bjlk,
I'd like to think that the company are as frustrated as we are. They just have more info on why they are frustrated to fill the info-void we are sat in.

One of the assumptions that I sooth my anxiety with is that both TT and CAP are having the same issues. I believe that to be a formulation issue. I tell myself that both companies are the subject of NDA's which prevent the management telling us what's happening so instead we get bed time stories for children with magic warehouses, whacky lids and weird tales of shelf life . Much of this narrative would barely satisfy Boris Johnsons grasp of reality let alone someone who pays attention to the detail.

My belief in the Strict NDA's suggests big player/s behind both so I'm hoping big news at some point but I'm not holding my breath.

[bjlk] 02/12/2019 12:48

The bod will be all too aware of the risks of disappointment.Really so why is the share price here, I honestly don't think they give a toss about the shareholders at all... happy to be proved wrong...

[supersonico] 02/12/2019 12:10

Chrischas,
They are selling or due to sell the formulations that work.
They are not yet selling the parallel delayed TT/CAP ++ formulations that needed improving/tweaking.
It's not a matter of not being able to sell imho it's a matter of getting the formulations ready for market.

[supersonico] 01/12/2019 19:13

Chrischas,
They are selling or due to sell the formulations that work.
They are not yet selling the parallel delayed TT/CAP ++ formulations that needed improving/tweaking.
It's not a matter of not being able to sell imho it's a matter of getting the formulations ready for market.

[investingisatrickygame] 01/12/2019 16:19

Chrischas

Agree with that.

You have to fight for every investor £1. There are another 1,000 companies on AIM alone, all no doubt looking for high growth.

Why should I invest in Eden Research?

If Eden can answer that question and communicate it to the right audience, the share price will surely rise.